GATAD2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.052600E-01
Normal-vs-Stage2
9.431200E-01
Normal-vs-Stage3
5.869000E-01
Normal-vs-Stage4
7.382600E-01
Stage1-vs-Stage2
7.265200E-01
Stage1-vs-Stage3
4.839400E-01
Stage1-vs-Stage4
7.202600E-01
Stage2-vs-Stage3
2.814200E-01
Stage2-vs-Stage4
8.010800E-01
Stage3-vs-Stage4
6.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.547400E-01
Normal-vs-AfricanAmerican
9.324200E-01
Normal-vs-Asian
8.758400E-01
Caucasian-vs-AfricanAmerican
6.572200E-01
Caucasian-vs-Asian
5.557200E-01
AfricanAmerican-vs-Asian
9.897600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.548400E-01
Normal-vs-Female
7.970600E-01
Male-vs-Female
4.937800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.710000E-01
Normal-vs-Age(41-60Yrs)
8.348800E-01
Normal-vs-Age(61-80Yrs)
7.284000E-01
Normal-vs-Age(81-100Yrs)
7.418800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.196200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.884800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.139000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.266300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.748000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.725960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.627200E-01
Normal-vs-Daily Drinker
5.221800E-01
Normal-vs-Weekly Drinker
9.472600E-01
Normal-vs-Occasional Drinker
9.137600E-01
Normal-vs-Social Drinker
4.381400E-01
Non Drinker-vs-Daily Drinker
2.519600E-01
Non Drinker-vs-Weekly Drinker
8.378000E-01
Non Drinker-vs-Occasional Drinker
7.618800E-01
Non Drinker-vs-Social Drinker
2.779200E-01
Daily Drinker-vs-Weekly Drinker
2.208800E-01
Daily Drinker-vs-Occasional Drinker
1.660770E-01
Daily Drinker-vs-Social Drinker
8.502000E-01
Weekly Drinker-vs-Occasional Drinker
9.424200E-01
Weekly Drinker-vs-Social Drinker
2.517000E-01
Occasional Drinker-vs-Social Drinker
2.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.765820E-01
Normal-vs-Grade 2
7.259800E-03
Normal-vs-Grade 3
1.720420E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.911800E-02
Grade 1-vs-Grade 3
2.265800E-02
Grade 1-vs-Grade 4
1.765820E-01
Grade 2-vs-Grade 3
7.582000E-01
Grade 2-vs-Grade 4
7.259800E-03
Grade 3-vs-Grade 4
1.720420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.583000E-01
Normal-vs-NonDiabetic
8.711600E-01
Diabetic-vs-NonDiabetic
8.722400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.394000E-01
Normal-vs-NoPancreatitis
8.244200E-01
Pancreatitis-vs-NoPancreatitis
7.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.436000E-01
Normal-vs-N1
9.327000E-01
N0-vs-N1
7.265400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.852200E-01
Normal-vs-TP53-NonMutant
5.713000E-01
TP53-Mutant-vs-TP53-NonMutant
4.880100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
